trending Market Intelligence /marketintelligence/en/news-insights/trending/viqfgj0oghydmmt-yowqjg2 content esgSubNav
In This List

Ritter Pharmaceuticals names CFO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Ritter Pharmaceuticals names CFO

Los Angeles-based Ritter Pharmaceuticals Inc. appointed John Beck as its CFO.

Beck, who has over 25 years of industry experience, is the former CFO of Ardea Biosciences Inc., which was acquired by AstraZeneca PLC for $1.26 billion in 2012, Ritter said.

"Beck's significant experience in public company management, his relationships within the investor community and his background in licensing and mergers and acquisitions will serve an important function for Ritter Pharmaceuticals as it moves into phase 3 clinical development with RP-G28 and prepares to commercialize this important asset, either alone or with partners, and build value for investors," Ritter CEO Michael Step said in a statement.

Ritter Pharmaceuticals is a specialty pharmaceutical company developing treatments for gastrointestinal diseases.